Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-13-000874
Filing Date
2013-05-06
Accepted
2013-05-06 19:51:39
Documents
1
Period of Report
2013-05-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7531
  Complete submission text file 0001078782-13-000874.txt   8986
Mailing Address
Business Address
BAUM MARK L (Reporting) CIK: 0001274282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 13817619

Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations